Morning Overview on MSN
An SGLT2 pill protected the kidneys of teenagers with type 1 diabetes in a new trial
Teenagers with type 1 diabetes now have the first randomized trial evidence that an SGLT2 inhibitor can protect their kidneys ...
Perry Wilson from Yale School of Medicine looked into longevity science. He highlighted two fundamental problems with the ...
Recent evidence on cash transfers and child health is mixed, suggesting that cash transfers may be a necessary but ...
Inside the cell nucleus, genes must be turned on and off with precision to regulate biological processes. The first models of ...
Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results